Plus   Neg

Stock Alert: Compugen Jumps 9%

Shares of Compugen Ltd. (CGEN) gained up 9% on Friday morning despite no stock-related news.

CGEN is currently trading at $13.93, up $1.10 or 8.57%, on the Nasdaq.

Compugen is a therapeutic company, which engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the US, and Europe. The company's therapeutic pipeline consists of immuno-oncology programs against novel drug targets, including T cell immune checkpoints and other early-stage immuno-oncology programs focusing on myeloid target.

Early this month, the company announced that the FDA has cleared the investigational new drug application for its Phase 1/2 study evaluating the triple combination of COM701, with Bristol Myers Squibb's Opdivo and TIGIT antibody, in patients with advanced solid tumors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The media mogul and Billionaire Sumner Redstone passed away on Tuesday at the age of 97, his family's holding company National Amusements said in a statement on Wednesday. He was Chairman Emeritus of ViacomCBS and chief executive officer of National Amusements. Customers in the U.S. are preferring digital or touchless payment methods due to concerns arising from the COVID-19 pandemic, a survey said. According to the survey by Rapyd Financial Network, the coronavirus pandemic has raised health and safety concerns around using cash and coins, and is accelerating the pre-existing trend toward digital transactions. American Airlines has extended its offer to waive change fees for customers who purchase tickets for travel, until December 31, 2020 in response to lower travel demand due to the coronavirus pandemic. This means that the travelers need not pay penalties for changing the origin and destination cities.
Follow RTT